Radiotherapeutic strategies in the management of hepatocellular carcinoma (Q37972813)

26 August 2017

title

Radiotherapeutic strategies in the management of hepatocellular carcinoma (English)

1 reference

26 August 2017

Ik Jae Lee

1

1 reference

26 August 2017

Jinsil Seong

series ordinal

2

1 reference

26 August 2017

publication date

22 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

81 Suppl 1

1 reference

26 August 2017

page(s)

123-133

1 reference

Global cancer statistics, 2002

26 August 2017

cites work

1 reference

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis

21 January 2018

1 reference

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Environmental factors and risk for hepatocellular carcinoma

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Hepatic toxicity resulting from cancer treatment.

21 January 2018

1 reference

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases

21 January 2018

1 reference

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

21 January 2018

1 reference

Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies--mature results of the French Phase II RTF-1 trial

21 January 2018

1 reference

Local radiotherapy for patients with unresectable hepatocellular carcinoma.

21 January 2018

1 reference

A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea

21 January 2018

1 reference

Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma

21 January 2018

1 reference

Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients

21 January 2018

1 reference

Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization.

21 January 2018

1 reference

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

21 January 2018

1 reference

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 January 2018

1 reference

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

21 January 2018

1 reference

Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.

21 January 2018

1 reference

Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma

21 January 2018

1 reference

Intraperitoneal hemorrhage from hepatocellular carcinoma: emergency chemoembolization or embolization

21 January 2018

1 reference

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

21 January 2018

1 reference

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

Chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity

21 January 2018

1 reference

Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma

21 January 2018

1 reference

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.

21 January 2018

1 reference

A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma.

21 January 2018

1 reference

Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma

21 January 2018

1 reference

Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease

21 January 2018

1 reference

Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

[Practice guidelines for management of hepatocellular carcinoma 2009].

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area

21 January 2018

1 reference

A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.

21 January 2018

1 reference

Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement

21 January 2018

1 reference

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

21 January 2018

1 reference

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

21 January 2018

1 reference

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis

21 January 2018

1 reference

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

21 January 2018

1 reference

Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma

21 January 2018

1 reference

Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma.

21 January 2018

1 reference

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

21 January 2018

1 reference

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis

21 January 2018

1 reference

Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers

21 January 2018

1 reference

Antiangiogenics and radiotherapy

21 January 2018

1 reference

High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies

21 January 2018

1 reference

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

21 January 2018

1 reference

Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiation

21 January 2018

1 reference

Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma

21 January 2018

1 reference

Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis

21 January 2018

1 reference

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

21 January 2018

1 reference

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases

21 January 2018

1 reference

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000333275

1 reference

26 August 2017

1 reference